Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS
· Delayed Price · Currency is USD
12.18
-0.49 (-3.89%)
At close: Mar 5, 2026
Sumitomo Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 4, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,735 | 1,934 | 1,045 | 2,421 | 3,952 | 6,922 | Upgrade
|
| Market Cap Growth | 128.80% | 85.01% | -56.82% | -38.75% | -42.91% | 33.63% | Upgrade
|
| Enterprise Value | 6,014 | 3,864 | 3,527 | 2,604 | 4,995 | 8,376 | Upgrade
|
| Last Close Price | 12.18 | 4.76 | 2.40 | 6.38 | 10.22 | 18.75 | Upgrade
|
| PE Ratio | 6.74 | 12.26 | - | - | 8.51 | 13.62 | Upgrade
|
| PS Ratio | 1.64 | 0.73 | 0.50 | 0.58 | 0.86 | 1.48 | Upgrade
|
| PB Ratio | 2.57 | 1.71 | 1.01 | 0.79 | 0.71 | 1.18 | Upgrade
|
| P/TBV Ratio | - | - | - | - | 34.15 | 37.03 | Upgrade
|
| P/FCF Ratio | 15.76 | 36.19 | - | 92.74 | 20.09 | 5.91 | Upgrade
|
| P/OCF Ratio | 13.93 | 17.55 | - | 26.96 | 15.36 | 5.65 | Upgrade
|
| EV/Sales Ratio | 2.09 | 1.45 | 1.70 | 0.62 | 1.08 | 1.80 | Upgrade
|
| EV/EBITDA Ratio | 7.28 | 15.00 | - | - | 6.17 | 12.04 | Upgrade
|
| EV/EBIT Ratio | 8.72 | 44.43 | - | - | 10.12 | 17.06 | Upgrade
|
| EV/FCF Ratio | 20.02 | 72.31 | - | 99.75 | 25.39 | 7.15 | Upgrade
|
| Debt / Equity Ratio | 0.90 | 1.85 | 2.74 | 0.85 | 0.42 | 0.45 | Upgrade
|
| Debt / EBITDA Ratio | 1.99 | 8.14 | - | - | 2.89 | 3.78 | Upgrade
|
| Debt / FCF Ratio | 5.50 | 39.27 | - | 99.82 | 11.91 | 2.24 | Upgrade
|
| Net Debt / Equity Ratio | 0.70 | 1.72 | 2.55 | 0.50 | 0.12 | 0.15 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.55 | 7.55 | -1.26 | -2.38 | 0.83 | 1.26 | Upgrade
|
| Net Debt / FCF Ratio | 4.28 | 36.38 | -1.58 | 58.47 | 3.41 | 0.75 | Upgrade
|
| Asset Turnover | 0.54 | 0.48 | 0.31 | 0.46 | 0.43 | 0.40 | Upgrade
|
| Inventory Turnover | 1.95 | 1.46 | 1.21 | 1.85 | 1.64 | 1.61 | Upgrade
|
| Quick Ratio | 0.91 | 0.43 | 0.25 | 0.65 | 1.27 | 1.19 | Upgrade
|
| Current Ratio | 1.40 | 1.07 | 0.52 | 1.03 | 1.79 | 1.65 | Upgrade
|
| Return on Equity (ROE) | 48.39% | 14.52% | -111.89% | -17.90% | 6.14% | 5.75% | Upgrade
|
| Return on Assets (ROA) | 8.13% | 0.99% | -21.74% | -6.46% | 2.86% | 2.65% | Upgrade
|
| Return on Invested Capital (ROIC) | 22.11% | 2.56% | -60.99% | -18.52% | 3.91% | 3.23% | Upgrade
|
| Return on Capital Employed (ROCE) | 18.00% | 2.60% | -90.60% | -16.50% | 5.80% | 5.30% | Upgrade
|
| Earnings Yield | 14.83% | 8.16% | -199.19% | -23.15% | 11.75% | 7.34% | Upgrade
|
| FCF Yield | 6.34% | 2.76% | -159.79% | 1.08% | 4.98% | 16.92% | Upgrade
|
| Dividend Yield | - | - | - | 2.48% | 2.26% | 1.35% | Upgrade
|
| Payout Ratio | 0.00% | 0.01% | - | - | 19.72% | 19.78% | Upgrade
|
| Total Shareholder Return | - | - | - | 2.48% | 2.26% | 1.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.